Login / Signup

Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.

Yujie YangQiannan MaZhiyu LiHui WangChenghu ZhangYajin LiuBochuan LiYingmei WangQinghua CuiFengxia XueDing AiYi ZhuJinlong He
Published in: British journal of pharmacology (2021)
Harmine alleviated OSS-induced EC activation via a PTPN14/YAPY357 pathway and had a potent atheroprotective role.
Keyphrases
  • endothelial cells
  • high glucose
  • signaling pathway
  • drug induced
  • protein protein
  • anti inflammatory
  • small molecule
  • mouse model
  • amino acid